期刊文献+

3718例泌尿系统肿瘤临床病理分析 被引量:4

下载PDF
导出
摘要 目的探讨泌尿系统肿瘤的发病趋势及临床病理特点。方法材料来自天津医科大学总医院病理科1980—2008年临床外检病理档案中泌尿系统肿瘤病例,应用SPSS11.5对该资料进行统计分析。结果29a间泌尿系统良、恶性肿瘤均呈上升趋势,良、恶性肿瘤好发部位均为膀胱,其次是肾脏;肾癌平均发病年龄低于膀胱癌。恶性肿瘤中膀胱、肾盂、输尿管和尿道组织学类型主要为尿路上皮癌,肾脏为透明细胞性肾细胞癌;膀胱良性肿瘤主要为内翻性乳头状瘤,肾脏为血管平滑肌脂肪瘤。结论29a来泌尿系统恶性肿瘤尤其是膀胱恶性肿瘤呈上升趋势,做好防治工作至关重要。
出处 《山东医药》 CAS 北大核心 2009年第48期79-80,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Eble .IN, Sauter G, Sterhen IA, et al. World Health Organization classification of tumours. Pathology and genetics the urinary system and male genital organs [M]. Lyon: IARC Press, 2004:9-157.
  • 2Parkin DM. The global burden of urinary bladder cancer [ J ]. Scand J Urol Nephrol Suppl, 2008, (218 ) : 12-20.
  • 3许斌(综述),华立新(审校).膀胱癌流行病学进展[J].国际泌尿系统杂志,2007,27(4):469-476. 被引量:14
  • 4Park HK, Zhang S, Wong MK, et al. Clinical presentation of epithelioid angiomyolipoma [J]. Int J Urol, 2007,14( 1 ) :21-25.
  • 5Lee JE, Spieqelman D, Hunter DJ, et al. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 pro- spective studies [ J ]. Natl Cancer Inst, 2008, 100 (23) : 1658- 1659.
  • 6Hoqervorst JG, Schouten LJ, Koninqs EJ, et al. Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer [J]. Am J Clin Nutr, 2008,87 ( 5 ) : 1428 -1438.

二级参考文献28

  • 1Mohr DN, Offord KP, Owen RA,et al. Asymptomatic microhematuria and urologic disease: a population -based study. JAMA, 1986, 256: 224 - 229.
  • 2Murphy WM : Urinary Cytopathology. Chicago, ASCP Press, 2000.
  • 3Mulders PFA, Meyden APVD, Doesburg WH, et al.fur the Dutch Southeastern Urological Collaborative Group. Prognostic factors in pT1 - pT1 superficial bladder tumors treated with intra vesical instillations. Br J Urol,1994,73:403 -408.
  • 4Pagano F, Garbeglio A, Milani C, et al. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma. Eur Urol, 1987,13 : 145 - 149.
  • 5Grimm MO, Steinhoff C, Simon X, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long - term observational study. J Urol,2003,170 : 433 - 437.
  • 6Konety BR,et al. Clinical usefulness of the novel marker BLCA -4 for the detection of bladder cancer. J Uroi,2000,164(3 Pt 1) :634 - 639.
  • 7Giannopoulos A, et al. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors. J Urol,2001,166 (2) :470 -475.
  • 8Sylvester RJ, et al. Bacillus calmette - guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta - analysis of the published results of randomized clinical trials. J Urol,2005,174( 1 ):86-91.
  • 9Dan Leibovici, et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. J Urol, 2006, 175 ( 6 ) : 2058 - 2062.
  • 10Honma l, Masumori N,et al. Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer - - analysis of role of pelvic lymph node dissection. Urology,2006,68(3) :543 -548.

共引文献13

同被引文献41

  • 1胡岚亭,郭峰,王胜军,倪泽称,汪清.PET/CT在泌尿系肿瘤诊断中的价值[J].中华临床医师杂志(电子版),2011,5(7):1951-1956. 被引量:10
  • 2王国民,陈伟.泌尿系统肿瘤治疗的进展与展望[J].肿瘤防治研究,2014,41(2):97-101. 被引量:25
  • 3沈莹.腹腔镜手术与开腹手术治疗大肠癌的护理对比观察[J].现代护理,2005,11(1):12-13. 被引量:15
  • 4周桥.WHO泌尿系统肿瘤分类(2004)及相关进展[J].临床与实验病理学杂志,2005,21(5):520-524. 被引量:2
  • 5Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin,2011,61 (2) :69 -90.
  • 6Ahmadi M,Ranjbaran H,Amiri MM,et al. Epidemiologic and so- cioeconomic status of bladder cancer in Mazandaran Province, northern Iran[ J]. Asian Pac J Cancer Prey,2012,13 (10) :5053 - 5056.
  • 7Yavari P, Sadrolhefazi B, Mohagheghi MA, et al. A descriptive ret- rospective study of bladder cancer at a hospital in Iran ( 1973 - 2003 ) [ J ]. Asian Pac J Cancer Prey,2009,10 (4) :681 - 684.
  • 8Salehi A,Khezri AA, Malekmakan L, et al. Epidemiologic status of bladder cancer in Shiraz, southern Iran [ J ]. Asian Pae J Cancer Prey,2011,12 (5) : 1323 - 1327.
  • 9Kirkali Z, Chart T, Manoharan M, et al. Bladder eancer:epidemiol- ogy, staging and grading, and diagnosis [ J ]. Urology, 2005,66 ( 6 Suppl 1) :4-34.
  • 10Samanic C, Kogevinas M, Dosemeci M, et al. Smoking and bladder cancer in Spain : effects of tobacco type, timing, environmental to- bacco smoke, and gender[ J ]. Cancer Epidemiol Biomarkers Prey, 2006,15(7) :1348 - 1354.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部